Kathi Niffenegger
2014
In 2014, Kathi Niffenegger earned a total compensation of $353K as Chief Financial Officer and Corporate Secretary at Edesa Biotech, a 73% increase compared to previous year.
Compensation breakdown
| Option Awards | $162,891 |
|---|---|
| Salary | $175,000 |
| Other | $15,080 |
| Total | $352,971 |
Niffenegger received $175K in salary, accounting for 50% of the total pay in 2014.
Niffenegger also received $162.9K in option awards and $15.1K in other compensation.
Rankings
In 2014, Kathi Niffenegger's compensation ranked 11,343rd out of 13,032 executives tracked by ExecPay. In other words, Niffenegger earned more than 13.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,343 out of 13,032 | 13th |
Division Manufacturing | 4,339 out of 4,966 | 13th |
Major group Chemicals And Allied Products | 1,501 out of 1,686 | 11th |
Industry group Drugs | 1,213 out of 1,365 | 11th |
Industry Pharmaceutical Preparations | 930 out of 1,043 | 11th |
Source: SEC filing on February 1, 2017.
Niffenegger's colleagues
We found four more compensation records of executives who worked with Kathi Niffenegger at Edesa Biotech in 2014.
News
Edesa Biotech CEO Pardeep Nijhawan's 2023 pay slips 9% to $550K
April 5, 2024
Edesa Biotech CEO Pardeep Nijhawan's 2022 pay falls 54% to $602K
March 28, 2023
Edesa Biotech CEO Pardeep Nijhawan's 2021 pay jumps 221% to $1.3M
April 1, 2022
Edesa Biotech President Michael Brooks' 2020 pay jumps 155% to $529K
March 3, 2021
Edesa Biotech President Michael Brooks' 2019 pay slips 10% to $207K
March 23, 2020